Complex therapy of acne: From theory to practice

This article discusses the relevance of the etiopathogenesis, clinic and effective treatment of acne depending on the form and stage of the disease. In accordance with the clinical recommendations of the Ministry of Health of the Russian Federation, acne vulgaris is a chronic inflammatory disease manifested by open or closed comedones and inflammatory skin lesions in the form of papules, pustules, and nodules. It is a multifactorial dermatosis in the pathogenesis of which genetically determined hyperandrogenism and a genetically determined type of sebaceous gland secretion play an important role. The incidence of acne in the population is 85–93%, with a steady increase in incidence in puberty and adulthood. Acne treatment is comprehensive – systemic drugs and mandatory local therapy, taking into account the main pathogenetic mechanisms. To achieve the positive effects of therapy, the article describes combined drugs that have a more pronounced therapeutic effect due to their selective action on follicular hyperkeratosis, the inflammatory process, reproduction and colonization of microorganisms. Azelaic acid preparations, as well as combinations of the antibiotic clindamycin and benzoyl peroxide, have such an effect on the affected skin. The publication examines various clinical cases of somatically healthy patients suffering from moderate acne. According to the doctor’s prescription, patients used combined external preparations strictly in accordance with clinical recommendations. At the end of the course of treatment, patients noted a significant improvement in the condition of the dermis in the form of minimizing the manifestations of acne. Careful study and further knowledge of the facts about the etiology and pathogenesis of acne, a wide range of drugs for external and systemic therapy of the disease, and the availability of a large amount of information make it possible to achieve significant improvements, minimal process alterations, and stable remission in the vast majority of patients.

1. Кубанов АА, Аравийская ЕА, Самцов АВ, Кондрахина ИН, Махакова ЮБ, Ласеев ДИ. Акне вульгарные: клинические рекомендации. М.; 2020. 33 с. Режим доступа: https://www.rodv.ru/upload/iblock/e74/e74c488d017cd6029c87c4b38753a7bf.docx.

2. Glazkova LK, Peretolchina TF, Utyaeva E.V. Modern approachs of treatment acne. Ural Medical Journal. 2008;(14):111–116. (In Russ.) Available at: https://elib.usma.ru/bitstream/usma/17295/1/UMJ_2008_54_028.pdf.

3. Dvoriankova EV, Denieva MI, Khismatullina ZR. Skin microbiome in patients with acne. Meditsinskiy Sovet. 2023;17(14):45–50. (In Russ.) https://doi.org/10.21518/ms2023-264.

4. Zagrtdinova RM, Zagrtdinova RN, Mustafaeva ESh. The possibilities of improving the effectiveness of acne therapy. Meditsinskiy Sovet. 2024;18(14):102–106. (In Russ.) https://doi.org/10.21518/ms2024-374.

5. Zhuraeva SSh. Azelaic acid is the drug of choice in topical acne therapy. Uspekhi Sovremennoy Nauki. 2017;2(3):174–176. (In Russ.) Available at: https://elibrary.ru/ynflqp.

6. Кovaleva YuS, Vedler AA, Karkhova VV. Micronization technology of in dermatology: therapeutic applications of azelaic acid. Klinicheskaya Dermatologiya i Venerologiya. 2018;17(6):13–20. (In Russ.) https://doi.org/10.17116/klinderma20181706113.

7. Kovaleva JuS, Reshetova SV, Nikolaeva MG. Focus on azelaic acid in topical rosacea therapy. Klinicheskaya Dermatologiya i Venerologiya. 2021;20(5): 103–108. (In Russ.) https://doi.org/10.17116/klinderma202120051103.

8. Kondratyeva YS, Kokina OA. Experience of applying azelaic acid in dermatology. Vestnik Dermatologii i Venerologii. 2016;92(3):139–144. (In Russ.) https://doi.org/10.25208/0042-4609-2016-92-3-139-144.

9. Круглова ЛС (ред.). Акне и розацеа. Клинические проявления, диагностика и лечение. М.: ГЭОТАР-Медиа; 2021. 208 с. Режим доступа: https://static-sl.insales.ru/files/1/5856/15152864/original/akne_i_rozacea_.pdf.

10. Silina LV, Pismennaya EV, Kolbina MS. Topical antibiotics for acne treatment. Vestnik Dermatologii i Venerologii. 2016;92(2):115–120. (In Russ.) https://doi.org/10.25208/0042-4609-2016-92-2-115-120.

11. Snarskaya ES. The role and place of azelaic acid in the routes of patients with acne vulgaris. Vestnik Dermatologii i Venerologii. 2020;96(5):65–70. (In Russ.) https://doi.org/10.25208/vdv1175-2020-96-5-65-70.

12. Faizullina EV, Khismatulina IM, Gordeeva AM. Treatment of acne complicated by concomitant mycobiota. Problems in Medical Mycology. 2019;21(4):30–33. (In Russ.) https://doi.org/10.24412/1999-6780-2019-4-30-33.

13. Khismatulina IM, Faizullina EV, Gusarova ES, Nabieva RR. Comparative evaluation of therapy results in mild acne. Meditsinskiy Sovet. 2022;16(13):24–30. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-13-24-30.

14. Leyden JJ. Effect of topical benzoyl peroxide/clindamycin versus topical clin-damycin and vehicle in the reduction of Propionibacterium acnes. Cutis. 2002;69(6):475–480. Available at: https://cdn.mdedge.com/files/s3fs-public/Document/September-2017/069060475.pdf.

15. Thiboutot DM, Dréno B, Abanmi A, Alexis AF, Araviiskaia E, Barona Cabal MI et al. Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018;78(2 Suppl. 1):S1–S23.e1. https://doi.org/10.1016/j.jaad.2017.09.078.

16. Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172(Suppl. 1):3–12. https://doi.org/10.1111/bjd.13462.

17. Nast A, Dréno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C et al. European evidence-based (S3) guideline for the treatment of acne – update 2016 – short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261–1268. https://doi.org/10.1111/jdv.13776.